Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Oct 13, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 12, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 11, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 10, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 09, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 06, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 05, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 04, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 03, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Oct 02, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Sep 29, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Sep 28, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Sep 27, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Sep 26, 2023 1.20€ 1.20€ 1.20€ 1.20€ 1 350
Sep 25, 2023 1.20€ 1.20€ 1.20€ 1.20€ 0
Sep 22, 2023 1.23€ 1.23€ 1.23€ 1.23€ 1 350
Sep 21, 2023 1.25€ 1.25€ 1.25€ 1.25€ 1 350
Sep 20, 2023 1.27€ 1.27€ 1.27€ 1.27€ 0
Sep 19, 2023 1.26€ 1.26€ 1.26€ 1.26€ 0
Sep 18, 2023 1.29€ 1.29€ 1.29€ 1.29€ 0
Sep 15, 2023 1.25€ 1.25€ 1.25€ 1.25€ 0
Sep 14, 2023 1.22€ 1.22€ 1.20€ 1.20€ 0
Sep 13, 2023 1.20€ 1.20€ 1.20€ 1.20€ 0
Sep 12, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Sep 11, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT